SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-023989
Filing Date
2023-07-07
Accepted
2023-07-07 16:17:03
Documents
29
Period of Report
2023-06-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 69723
2 ex3-1.htm EX-3.1 2153
3 ex3-2.htm EX-3.2 10221
4 ex3-3.htm EX-3.3 107015
5 ex3-1_001.jpg GRAPHIC 1074750
6 ex3-1_002.jpg GRAPHIC 652405
7 ex3-2_001.jpg GRAPHIC 457104
8 ex3-2_002.jpg GRAPHIC 343706
9 ex3-2_003.jpg GRAPHIC 290290
10 ex3-2_004.jpg GRAPHIC 341632
11 ex3-2_005.jpg GRAPHIC 327410
12 ex3-2_006.jpg GRAPHIC 327555
13 ex3-2_007.jpg GRAPHIC 321088
14 ex3-2_008.jpg GRAPHIC 314652
15 ex3-2_009.jpg GRAPHIC 308371
16 ex3-2_010.jpg GRAPHIC 307741
17 ex3-2_011.jpg GRAPHIC 321148
18 ex3-2_012.jpg GRAPHIC 136988
  Complete submission text file 0001493152-23-023989.txt   7999242

Data Files

Seq Description Document Type Size
19 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vodg-20230630.xsd EX-101.SCH 3033
20 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vodg-20230630_lab.xml EX-101.LAB 34240
21 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vodg-20230630_pre.xml EX-101.PRE 22371
23 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3227
Mailing Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403
Business Address 4621 TECHNOLOGY DRIVE GOLDEN CO 80403 (720) 859-4120
Vitro Biopharma, Inc. (Filer) CIK: 0000793171 (see all company filings)

IRS No.: 841012042 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-17378 | Film No.: 231076982
SIC: 2836 Biological Products, (No Diagnostic Substances)